InvestorsHub Logo
Followers 32
Posts 4083
Boards Moderated 1
Alias Born 06/08/2003

Re: None

Wednesday, 05/01/2013 7:59:23 AM

Wednesday, May 01, 2013 7:59:23 AM

Post# of 156
Melbourne Australia; 24 April 2013 - Starpharma Holdings Ltd (ASX: SPL; OTCQX:

(excerpt)
SPHRY) today released its Appendix 4C – Quarterly Cashflow report for the period ended 31 March 2013.

The cash balance at 31 March was $35.9 million following the receipt of a $5.4 million R&D tax incentive refund. This represents a net increase of $2.7 million on the previous quarter.

https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=103015

I am only expressing my personal opinions or repeating public information from SEC filings or media outlets-which may or may not be correct. Do your own investigating before investing!